Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Preiss

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Maturitas|March 27, 2012
Statin therapy and new-onset diabetes: a cause for concern?David Preiss
The Lancet. Diabetes & Endocrinology|September 14, 2014
Do statins reduce microvascular complications in diabetes?David Preiss
Expert Review of Gastroenterology & Hepatology|March 1, 2013
Triglyceride levels, pancreatitis and choice of lipid-modifying therapyDavid Preiss
Nature Reviews. Cardiology|February 15, 2012
Pharmacotherapy: Statins and new-onset diabetes--the important questionsDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|August 14, 2017
Research digest: more cardiovascular outcome trials in diabetesNaveed Sattar, David Preiss
Diabetologia|December 28, 2016
PCSK9 inhibition: the dawn of a new age in cholesterol lowering?David Preiss, Marion Mafham
The Lancet. Diabetes & Endocrinology|April 12, 2017
Research digest: the risks of type 2 diabetes at a young ageNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|April 4, 2016
Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testingNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|February 13, 2017
Research digest: prediabetes definitions and diabetes preventionNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|May 20, 2019
Research digest: SGLT2 inhibition in kidney and liver diseaseDavid Preiss, Naveed Sattar
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Maturitas|March 27, 2012
Statin therapy and new-onset diabetes: a cause for concern?David Preiss
The Lancet. Diabetes & Endocrinology|September 14, 2014
Do statins reduce microvascular complications in diabetes?David Preiss
Expert Review of Gastroenterology & Hepatology|March 1, 2013
Triglyceride levels, pancreatitis and choice of lipid-modifying therapyDavid Preiss
Nature Reviews. Cardiology|February 15, 2012
Pharmacotherapy: Statins and new-onset diabetes--the important questionsDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|August 14, 2017
Research digest: more cardiovascular outcome trials in diabetesNaveed Sattar, David Preiss
Diabetologia|December 28, 2016
PCSK9 inhibition: the dawn of a new age in cholesterol lowering?David Preiss, Marion Mafham
The Lancet. Diabetes & Endocrinology|April 12, 2017
Research digest: the risks of type 2 diabetes at a young ageNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|April 4, 2016
Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testingNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|February 13, 2017
Research digest: prediabetes definitions and diabetes preventionNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|May 20, 2019
Research digest: SGLT2 inhibition in kidney and liver diseaseDavid Preiss, Naveed Sattar
Pageof 16